Atlas Trials

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)

Clinical trial NCT06099080 · UNKNOWN

Trial details

NCT number
NCT06099080
Sponsor
DermBiont, Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Dermatosis Papulosa Nigra
Start date
2023-11-07
Primary completion
2024-07-25
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.